Protein pamitoylation, Palmitoyltransferase
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0005783 | endoplasmic reticulum | 5 | 2 |
GO:0005794 | Golgi apparatus | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
Related structures:
AlphaFold database: A4HV17
Term | Name | Level | Count |
---|---|---|---|
GO:0006497 | protein lipidation | 5 | 2 |
GO:0006605 | protein targeting | 5 | 2 |
GO:0006612 | protein targeting to membrane | 5 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0006810 | transport | 3 | 2 |
GO:0006886 | intracellular protein transport | 4 | 2 |
GO:0006897 | endocytosis | 5 | 2 |
GO:0008104 | protein localization | 4 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0015031 | protein transport | 4 | 2 |
GO:0016192 | vesicle-mediated transport | 4 | 2 |
GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
GO:0018198 | peptidyl-cysteine modification | 6 | 2 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 7 | 2 |
GO:0018231 | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 7 | 2 |
GO:0018345 | protein palmitoylation | 6 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0033036 | macromolecule localization | 2 | 2 |
GO:0036211 | protein modification process | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0043543 | protein acylation | 5 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0045184 | establishment of protein localization | 3 | 2 |
GO:0046907 | intracellular transport | 3 | 2 |
GO:0051179 | localization | 1 | 2 |
GO:0051234 | establishment of localization | 2 | 2 |
GO:0051641 | cellular localization | 2 | 2 |
GO:0051649 | establishment of localization in cell | 3 | 2 |
GO:0051668 | localization within membrane | 3 | 2 |
GO:0070727 | cellular macromolecule localization | 3 | 2 |
GO:0071702 | organic substance transport | 4 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0071705 | nitrogen compound transport | 4 | 2 |
GO:0072657 | protein localization to membrane | 4 | 2 |
GO:0090150 | establishment of protein localization to membrane | 4 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0016409 | palmitoyltransferase activity | 5 | 11 |
GO:0016417 | S-acyltransferase activity | 5 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016746 | acyltransferase activity | 3 | 11 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 11 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 4 | 11 |
GO:0019707 | protein-cysteine S-acyltransferase activity | 3 | 11 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 327 | 331 | PF00656 | 0.380 |
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.670 |
CLV_NRD_NRD_1 | 223 | 225 | PF00675 | 0.683 |
CLV_NRD_NRD_1 | 235 | 237 | PF00675 | 0.617 |
CLV_NRD_NRD_1 | 325 | 327 | PF00675 | 0.633 |
CLV_PCSK_FUR_1 | 233 | 237 | PF00082 | 0.601 |
CLV_PCSK_KEX2_1 | 111 | 113 | PF00082 | 0.670 |
CLV_PCSK_KEX2_1 | 223 | 225 | PF00082 | 0.702 |
CLV_PCSK_KEX2_1 | 235 | 237 | PF00082 | 0.628 |
CLV_PCSK_KEX2_1 | 324 | 326 | PF00082 | 0.636 |
CLV_PCSK_KEX2_1 | 443 | 445 | PF00082 | 0.694 |
CLV_PCSK_PC1ET2_1 | 443 | 445 | PF00082 | 0.694 |
CLV_PCSK_SKI1_1 | 13 | 17 | PF00082 | 0.647 |
CLV_PCSK_SKI1_1 | 236 | 240 | PF00082 | 0.698 |
DOC_CKS1_1 | 66 | 71 | PF01111 | 0.487 |
DOC_MAPK_MEF2A_6 | 401 | 409 | PF00069 | 0.518 |
DOC_PP4_FxxP_1 | 239 | 242 | PF00568 | 0.514 |
DOC_PP4_FxxP_1 | 448 | 451 | PF00568 | 0.407 |
DOC_USP7_MATH_1 | 118 | 122 | PF00917 | 0.445 |
DOC_USP7_MATH_1 | 146 | 150 | PF00917 | 0.477 |
DOC_USP7_MATH_1 | 200 | 204 | PF00917 | 0.462 |
DOC_USP7_MATH_1 | 214 | 218 | PF00917 | 0.539 |
DOC_USP7_MATH_1 | 242 | 246 | PF00917 | 0.497 |
DOC_USP7_MATH_1 | 34 | 38 | PF00917 | 0.505 |
DOC_USP7_UBL2_3 | 335 | 339 | PF12436 | 0.435 |
DOC_WW_Pin1_4 | 180 | 185 | PF00397 | 0.413 |
DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.572 |
DOC_WW_Pin1_4 | 57 | 62 | PF00397 | 0.483 |
DOC_WW_Pin1_4 | 65 | 70 | PF00397 | 0.485 |
DOC_WW_Pin1_4 | 74 | 79 | PF00397 | 0.504 |
LIG_14-3-3_CanoR_1 | 241 | 247 | PF00244 | 0.431 |
LIG_14-3-3_CanoR_1 | 433 | 438 | PF00244 | 0.324 |
LIG_Actin_WH2_2 | 419 | 435 | PF00022 | 0.365 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.465 |
LIG_BIR_III_4 | 187 | 191 | PF00653 | 0.482 |
LIG_BRCT_BRCA1_1 | 101 | 105 | PF00533 | 0.455 |
LIG_BRCT_BRCA1_1 | 262 | 266 | PF00533 | 0.530 |
LIG_BRCT_BRCA1_1 | 287 | 291 | PF00533 | 0.258 |
LIG_BRCT_BRCA1_1 | 396 | 400 | PF00533 | 0.580 |
LIG_FHA_1 | 181 | 187 | PF00498 | 0.412 |
LIG_FHA_1 | 25 | 31 | PF00498 | 0.495 |
LIG_FHA_1 | 445 | 451 | PF00498 | 0.419 |
LIG_FHA_2 | 325 | 331 | PF00498 | 0.380 |
LIG_LIR_Apic_2 | 445 | 451 | PF02991 | 0.391 |
LIG_LIR_Gen_1 | 358 | 367 | PF02991 | 0.404 |
LIG_LIR_Gen_1 | 370 | 378 | PF02991 | 0.338 |
LIG_LIR_Gen_1 | 434 | 441 | PF02991 | 0.388 |
LIG_LIR_Nem_3 | 263 | 269 | PF02991 | 0.512 |
LIG_LIR_Nem_3 | 358 | 363 | PF02991 | 0.407 |
LIG_LIR_Nem_3 | 370 | 375 | PF02991 | 0.350 |
LIG_LIR_Nem_3 | 434 | 440 | PF02991 | 0.373 |
LIG_MLH1_MIPbox_1 | 396 | 400 | PF16413 | 0.580 |
LIG_PCNA_yPIPBox_3 | 277 | 285 | PF02747 | 0.624 |
LIG_Pex14_1 | 262 | 266 | PF04695 | 0.530 |
LIG_Pex14_2 | 287 | 291 | PF04695 | 0.310 |
LIG_Pex14_2 | 303 | 307 | PF04695 | 0.288 |
LIG_SH2_CRK | 253 | 257 | PF00017 | 0.358 |
LIG_SH2_PTP2 | 269 | 272 | PF00017 | 0.530 |
LIG_SH2_SRC | 246 | 249 | PF00017 | 0.317 |
LIG_SH2_SRC | 437 | 440 | PF00017 | 0.408 |
LIG_SH2_STAT5 | 253 | 256 | PF00017 | 0.398 |
LIG_SH2_STAT5 | 269 | 272 | PF00017 | 0.398 |
LIG_SH2_STAT5 | 273 | 276 | PF00017 | 0.555 |
LIG_SH2_STAT5 | 360 | 363 | PF00017 | 0.317 |
LIG_SH2_STAT5 | 399 | 402 | PF00017 | 0.547 |
LIG_SH2_STAT5 | 427 | 430 | PF00017 | 0.426 |
LIG_SH3_2 | 40 | 45 | PF14604 | 0.466 |
LIG_SH3_3 | 176 | 182 | PF00018 | 0.504 |
LIG_SH3_3 | 25 | 31 | PF00018 | 0.545 |
LIG_SH3_3 | 37 | 43 | PF00018 | 0.499 |
LIG_SH3_3 | 66 | 72 | PF00018 | 0.542 |
LIG_SUMO_SIM_par_1 | 192 | 197 | PF11976 | 0.453 |
LIG_TRAF2_1 | 451 | 454 | PF00917 | 0.392 |
LIG_TYR_ITSM | 433 | 440 | PF00017 | 0.408 |
LIG_WRC_WIRS_1 | 372 | 377 | PF05994 | 0.417 |
MOD_CDK_SPK_2 | 180 | 185 | PF00069 | 0.413 |
MOD_CDK_SPK_2 | 57 | 62 | PF00069 | 0.474 |
MOD_CDK_SPK_2 | 68 | 73 | PF00069 | 0.457 |
MOD_CDK_SPxxK_3 | 68 | 75 | PF00069 | 0.473 |
MOD_CDK_SPxxK_3 | 78 | 85 | PF00069 | 0.450 |
MOD_CK1_1 | 155 | 161 | PF00069 | 0.440 |
MOD_CK1_1 | 370 | 376 | PF00069 | 0.450 |
MOD_CK2_1 | 206 | 212 | PF00069 | 0.470 |
MOD_CK2_1 | 78 | 84 | PF00069 | 0.525 |
MOD_Cter_Amidation | 441 | 444 | PF01082 | 0.563 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.696 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.669 |
MOD_GlcNHglycan | 117 | 121 | PF01048 | 0.655 |
MOD_GlcNHglycan | 152 | 157 | PF01048 | 0.721 |
MOD_GlcNHglycan | 166 | 170 | PF01048 | 0.678 |
MOD_GlcNHglycan | 315 | 318 | PF01048 | 0.580 |
MOD_GlcNHglycan | 367 | 370 | PF01048 | 0.530 |
MOD_GlcNHglycan | 396 | 399 | PF01048 | 0.380 |
MOD_GSK3_1 | 225 | 232 | PF00069 | 0.530 |
MOD_GSK3_1 | 324 | 331 | PF00069 | 0.435 |
MOD_GSK3_1 | 367 | 374 | PF00069 | 0.359 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.532 |
MOD_N-GLC_2 | 338 | 340 | PF02516 | 0.636 |
MOD_N-GLC_2 | 352 | 354 | PF02516 | 0.470 |
MOD_NEK2_1 | 165 | 170 | PF00069 | 0.564 |
MOD_NEK2_1 | 260 | 265 | PF00069 | 0.530 |
MOD_NEK2_1 | 303 | 308 | PF00069 | 0.504 |
MOD_NEK2_1 | 432 | 437 | PF00069 | 0.382 |
MOD_NEK2_1 | 56 | 61 | PF00069 | 0.522 |
MOD_NEK2_2 | 286 | 291 | PF00069 | 0.306 |
MOD_PIKK_1 | 271 | 277 | PF00454 | 0.599 |
MOD_PKA_1 | 324 | 330 | PF00069 | 0.435 |
MOD_PKA_1 | 458 | 464 | PF00069 | 0.401 |
MOD_PKA_2 | 110 | 116 | PF00069 | 0.434 |
MOD_PKA_2 | 229 | 235 | PF00069 | 0.545 |
MOD_PKA_2 | 324 | 330 | PF00069 | 0.435 |
MOD_PKA_2 | 394 | 400 | PF00069 | 0.566 |
MOD_PKA_2 | 432 | 438 | PF00069 | 0.290 |
MOD_Plk_1 | 444 | 450 | PF00069 | 0.405 |
MOD_Plk_1 | 45 | 51 | PF00069 | 0.533 |
MOD_Plk_4 | 261 | 267 | PF00069 | 0.530 |
MOD_Plk_4 | 286 | 292 | PF00069 | 0.431 |
MOD_Plk_4 | 367 | 373 | PF00069 | 0.436 |
MOD_Plk_4 | 377 | 383 | PF00069 | 0.395 |
MOD_Plk_4 | 99 | 105 | PF00069 | 0.472 |
MOD_ProDKin_1 | 180 | 186 | PF00069 | 0.413 |
MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.573 |
MOD_ProDKin_1 | 57 | 63 | PF00069 | 0.484 |
MOD_ProDKin_1 | 65 | 71 | PF00069 | 0.487 |
MOD_ProDKin_1 | 74 | 80 | PF00069 | 0.503 |
TRG_ENDOCYTIC_2 | 253 | 256 | PF00928 | 0.391 |
TRG_ENDOCYTIC_2 | 269 | 272 | PF00928 | 0.398 |
TRG_ENDOCYTIC_2 | 299 | 302 | PF00928 | 0.530 |
TRG_ENDOCYTIC_2 | 360 | 363 | PF00928 | 0.435 |
TRG_ENDOCYTIC_2 | 427 | 430 | PF00928 | 0.435 |
TRG_ENDOCYTIC_2 | 437 | 440 | PF00928 | 0.317 |
TRG_ER_diArg_1 | 111 | 114 | PF00400 | 0.468 |
TRG_ER_diArg_1 | 223 | 225 | PF00400 | 0.499 |
TRG_ER_diArg_1 | 233 | 236 | PF00400 | 0.468 |
TRG_ER_diArg_1 | 324 | 326 | PF00400 | 0.380 |
TRG_ER_diArg_1 | 72 | 75 | PF00400 | 0.472 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S5H6J6 | Leishmania donovani | 100% | 100% |
A0A3S7WRS6 | Leishmania donovani | 53% | 89% |
A4H6N2 | Leishmania braziliensis | 41% | 100% |
A4H6N3 | Leishmania braziliensis | 64% | 100% |
A4HV16 | Leishmania infantum | 53% | 89% |
E9ANQ1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 45% | 74% |
E9ANQ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
Q4QGX1 | Leishmania major | 90% | 96% |
Q4QGX2 | Leishmania major | 52% | 89% |